Measuring the Effects of Talazoparib in Patients With Advanced Cancer and DNA Repair Variations
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Seagen Inc.
Hoffmann-La Roche
National Institutes of Health Clinical Center (CC)
Bayer
Psyence Australia Pty Ltd
Convalife (Shanghai) Co., Ltd.
University of California, Irvine
Jazz Pharmaceuticals
Daiichi Sankyo
HealthPartners Institute
Brigham and Women's Hospital
Mayo Clinic
City of Hope Medical Center
Bayer
Astellas Pharma Inc
Tempus AI
Pfizer
British Columbia Cancer Agency
University of California, Irvine
Tongji Hospital
Memorial Sloan Kettering Cancer Center
Elevation Oncology
Actuate Therapeutics Inc.
Dana-Farber Cancer Institute
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Zhejiang Provincial People's Hospital
Columbia University
Exelixis
Erasmus Medical Center
Universitair Ziekenhuis Brussel
Fondazione per la Medicina Personalizzata
pharmaand GmbH
Hoffmann-La Roche
OncoNano Medicine, Inc.
Jules Bordet Institute
Karolinska University Hospital
Ambrx, Inc.
Main Line Health
University of Kansas Medical Center
ExcellaBio LLC
Wake Forest University Health Sciences
National Institutes of Health Clinical Center (CC)
Abramson Cancer Center at Penn Medicine
Advanced Accelerator Applications
MetiMedi Pharmaceuticals
Sun Yat-sen University
Cambridge University Hospitals NHS Foundation Trust
Institut de Cancérologie de la Loire